SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility and intense community focus as traders react to major structural catalysts, including the upcoming US listing of SK Hynix, a 20-for-1 stock split, and aggressive rebalancing by the South Korean National Pension Service. The stock remains a center of heated debate between bullish retail traders expecting a multi-year AI memory super-cycle and bearish participants concerned about excessive leverage, systemic risk, and the impact of KOSPI-driven technical sell-offs.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors digest the recent Annual General Meeting updates, where leadership emphasized the company's production ramp, a significant cash balance, and the expansion of its customer pipeline into 2026. The stock is seeing heightened volatility as the community debates whether the current price represents a buying opportunity or a technical breakdown, with active discussion focused on the potential for institutional validation from recent 13G filings.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is trending due to a powerful combination of strong earnings performance and validation as an NVIDIA AI Factory Specialized Partner. Community sentiment is divided between bulls betting on a multi-year AI infrastructure demand cycle and bears cautioning against potential overextension following the stock's sharp year-to-date gains.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is seeing intense community engagement and high volatility following a massive 20-year infrastructure deal with AI firm Anthropic and subsequent analyst price target upgrades. While bulls are touting the long-term potential of the companys AI data center expansion, the stock is facing significant downward pressure from short-term traders and broader market sector rotations.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The semiconductor sector is facing increased volatility and profit-taking as investors rotate out of crowded AI-linked positions, fueled by concerns over data center capacity and unsustainable valuation growth. While memory names like Micron remain a focal point for institutional demand, the market is currently navigating a sharp repricing phase that has pressured major chip benchmarks like SMH.

PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of beverages, food, and snacks. It operates through the following business segments: PepsiCo Foods North America (PFNA), PepsiCo Beverages North America (PBNA), International Beverages Franchise (IB Franchise), Europe, Middle East and Africa (EMEA), Latin America Foods (LatAm Foods), and Asia Pacific Foods. The PFNA segment refers to the food businesses in the United States and Canada. The PBNA segment includes beverage businesses in the United States and Canada. The IB Franchise segment involves the international franchise beverage businesses, as well as the SodaStream business. The EMEA segment pertains to food businesses and beverage businesses with company-owned bottlers in Europe, the Middle East, and Africa. The LatAm Foods segment consists of food businesses in Latin America. The Asia Pacific Foods segment is associated in food businesses in Asia Pacific, including China, Australia and New Zealand, as well as India. The company was founded by Donald M. Kendall, Sr. and Herman W. Lay in 1965 and is headquartered in Purchase, NY.

PepsiCo Inc

PepsiCo is generating significant investor attention as it reports quarterly results, with the community closely tracking whether recent price-cut strategies have successfully revitalized North American snack volumes. Investors are simultaneously debating the stock's valuation gap compared to Coca-Cola, weighing the defensive stability of its dividend against ongoing concerns regarding beverage segment growth and shifting consumer health preferences.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is experiencing significant market volatility and a sharp price decline following a massive restructuring charge and the suspension of its dividend, as the company pivots away from a failed EV-heavy strategy toward consumer-preferred hybrid and combustion models. While some investors view the stock as deeply undervalued and a contrarian turnaround opportunity, the broader community remains divided, expressing frustration over vehicle quality issues and high inventory levels while debating the long-term viability of the brand lineup.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF is facing heightened volatility and sharp declines as the market reacts to geopolitical tensions and energy supply concerns linked to the conflict in the Middle East. Despite the aggressive sell-off, community discussion remains focused on the long-term outlook for major memory chip leaders like Samsung and SK Hynix, with many investors debating whether to buy the dip or exercise caution amid the broader AI sector's repricing.

Roundhill ETF Trust - Roundhill Memory ETF

Roundhill Memory ETF is facing significant volatility as investors digest weaker-than-expected earnings guidance from major industry players like Samsung, fueling broader concerns about the memory chip sector's cyclical outlook. Community sentiment is deeply divided, with bears pointing to oversupply and potential sector cooling while bulls advocate for a long-term 'supercycle' thesis driven by persistent AI infrastructure and HBM demand.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) is currently a focal point for traders as markets digest the highly anticipated Nasdaq listing of SK Hynix, which has generated significant buzz due to an artificial scarcity strategy that resulted in the deal being seven times oversubscribed. While some market participants are expressing caution over the AI sector's frothy valuations and potential oversupply risks, the community remains intensely divided between those betting on a correction and those continuing to buy the dip, with heightened focus on how this major foreign listing will influence the broader memory and AI supply chain landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ALT Q1 &#39;25 Earnings Results &amp; Recap

Altimmune&#39;s Q1 &#39;25 EPS of -$0.26 exceeded the -$0.35 estimate, while revenue remained at 0M as expected; the company anticipates positive Phase 2b trial results, but faces financial challenges despite a new $100M credit facility.

Ben Fowler

Noah Portillo

StockTwits Web

Bobby Hatton

$ALT the estimate was -$0.35, not $0.35. So isnt the actual EPS of -$0.26 a positive? Not a negative?

Michael Gutierrez

Stocktwits

Altimmune Inc

 Q1 '25 Earnings Results & Recap

Altimmune's Q1 '25 EPS of -$0.26 exceeded the -$0.35 estimate, while revenue remained at 0M as expected; the company anticipates positive Phase 2b trial results, but faces financial challenges despite a new $100M credit facility.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Patricia

Abra Hamburger

Jennifer

Billy Biggs

BusterScruggsFancyDan

Observer Explorer

Michael Moore

Seaney the Bull

Patrick R.

Allen Bram

ALAS

@StocktwitsEarnings I&#39;m gonna send this shit to the SEC !

Peter Quick

@StocktwitsEarnings I see stocktwits is still helping spread FUD against this small caps biotech. Their collusion on paid Fear, Uncertainty, and Doubt is all being documented and sent to the SEC for immediate investigation.

allison gero

 I see stocktwits is still helping spread FUD against this small caps biotech. Their collusion on paid Fear, Uncertainty, and Doubt is all being documented and sent to the SEC for immediate investigation.

Jim Patrick

@StocktwitsEarnings &quot;The Q1 &#39;25 earnings report shows a net loss of $19.6 million (-$0.26/share), exceeding the -$0.35 EPS estimate, but still reflecting ongoing operational losses.&quot; 
 
what? did recently dumbed down ChatGPT write this?

 "The Q1 '25 earnings report shows a net loss of $19.6 million (-$0.26/share), exceeding the -$0.35 EPS estimate, but still reflecting ongoing operational losses." 
 
what? did recently dumbed down ChatGPT write this?

Justin Smith

@StocktwitsEarnings Along with the blatant incorrectness that has already been noted by others, you might look even a little more credible if you even got the drug name correct as well SMH it is PEMVIDUTIDE.

Hewitts

StockTwits for iOS

 Along with the blatant incorrectness that has already been noted by others, you might look even a little more credible if you even got the drug name correct as well SMH it is PEMVIDUTIDE.

@StocktwitsEarnings ST loves to lie and can barely speak English.

 ST loves to lie and can barely speak English.

Steve Graves

@StocktwitsEarnings ST would be better off if they stopped being for sale to the highest bidder.

 ST would be better off if they stopped being for sale to the highest bidder.

@StocktwitsEarnings $PREDICT $ROAST  
$ALT Altimmune downgraded and new PT assigned followed concerning Q1 Earnings Call.  
 
BioRich Capital has downgraded Altimmune to a &quot;Strong Sell&quot; and 1-year PT of $2.69.   
 
Factors contributing to this target include: 
1) Company History and Management Business Practices. 
2) Concerns Regarding Company&#39;s Financial Position. 
3) Company-related Data Integrity Concerns. 
4) Discontinuation of Obesity Program. 
5) Uncertainty related to pending and future data readouts. 
6) Company&#39;s approach and engagement with the FDA. 
7) Increased and improvement in competition. 
8) Long periods of data drought ahead.  
9) Current SP inflated. 
10) Lack of trust in company (MAJOR RED FLAG). 
 
After thorough technical analysis, a one-year PT of $2.69 appears relevant.  As this represents an ~55% decline from today&#39;s opening SP, a &quot;Strong Sell&quot; rating has been applied. 
 
Follow/Subscribe for more suggestions and perspective. 
Cheers! 
 
$XBI $SPY

StockTwits Predictions

SPDR S&P Biotech ETF

 Altimmune downgraded and new PT assigned followed concerning Q1 Earnings Call.  
 
BioRich Capital has downgraded Altimmune to a "Strong Sell" and 1-year PT of $2.69.   
 
Factors contributing to this target include: 
1) Company History and Management Business Practices. 
2) Concerns Regarding Company's Financial Position. 
3) Company-related Data Integrity Concerns. 
4) Discontinuation of Obesity Program. 
5) Uncertainty related to pending and future data readouts. 
6) Company's approach and engagement with the FDA. 
7) Increased and improvement in competition. 
8) Long periods of data drought ahead.  
9) Current SP inflated. 
10) Lack of trust in company (MAJOR RED FLAG). 
 
After thorough technical analysis, a one-year PT of $2.69 appears relevant.  As this represents an ~55% decline from today's opening SP, a "Strong Sell" rating has been applied. 
 
Follow/Subscribe for more suggestions and perspective. 
Cheers! 
 


The Legendary Mayor

@StocktwitsEarnings you’ve been reported